02.23.2026
Palliative Pearls
01.20.2026
Huntington’s Disease: A Primer on Chorea
Huntington’s Disease Huntington’s disease (HD) is an incurable and progressive neurogenic disorder.1,2 It is categorized as a movement disorder, alongside Parkinson’s disease, Lewy body dementia,...
12.12.2025
Top 3 Clinical Case Studies and Reviews in 2025 from Enclara Pharmacia
This year’s Palliative Pearls case studies explored a variety of topics, from basic prescribing decisions to exploring the full continuum of care. If there’s a...
11.17.2025
Managing Pulmonary Hypertension in Hospice Care: A Revision
This month, we are pleased to present a renewed look at one of our popular Palliative Pearls cases, originally featured in March 2019. In this...
10.21.2025
Clozapine Therapy: Overview and Place in Hospice & Palliative Care
Recently, the U.S. Food and Drug Administration (FDA) removed the Risk Evaluation and Mitigation Strategies (REMS)1 program for clozapine (Clozaril® tablets, Fazaclo® orally disintegrating tablets,...
09.23.2025
Advanced Parkinson’s Disease: Considerations for Patient Management in Transition to Hospice Services
BACKGROUND ON PARKINSON’S DISEASE Parkinson’s disease (PD) is a degenerative central nervous system disorder resulting from degeneration of dopamine-producing neurons in the section of the...
08.19.2025
A Primer on Patches: Overview of Transdermal Medication Patches in Hospice and Palliative Care
Transdermal medication patches can offer a non-invasive option of medication delivery for patients who are unable to swallow oral formulations. Several common medications for symptom...
07.22.2025
Navigating the Hospice IPU Landscape for Symptom Management
Introduction: Understanding the IPU and GIP Level of Care The Inpatient Hospice Unit (IPU) plays a pivotal role in the continuum of hospice care, providing...
06.18.2025